NCT03181438

Efficacy Transverse Abdominal Plane (TAP) Block Renal Transplant Surgery

Efficacy of Ultrasound-guided Transverse Abdominal Plane Block for Analgesia in Renal Transplantation

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 42 (estimated)
• Sponsor: Federal University of São Paulo · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to evaluate the efficacy and safety of transverse abdominal plane block in patients undergoing renal transplant surgery.Adult renal transplant recipients will be prospectively randomized to receive a standard general anesthetic technique supplemented with ropivacaine 0.375% 20 mL TAP block or sham block with 20 mL 0.9% saline. Both groups will receive patient-controlled morphine analgesia. Patient assessment will occur in the postanesthetic care unit and at 1, 2, 4, 6, 12, and 24 hours. The primary outcome is total morphine consumption in the first 24 hours after renal transplantation. Other outcomes asses include pain scores, presence of nausea or vomiting, excessive sedation, and respiratory depression.

Conditions

• Renal Insufficiency, Chronic
• Acute Pain
• Kidney Transplantation
• Anesthesia, Conduction

Interventions

Type	Name	Description
PROCEDURE	TAP Block	It will be performed a ultrasound-guided transverse abdominal plane block with 20 ml of 0.375% of ropivacaine for patients submitted to renal transplantation
PROCEDURE	Saline Group	t will be performed a ultrasound-guided transverse abdominal plane block with 2o mL of saline for patients submitted to renal transplantation

Timeline

• Start date: 2017-06-03
• Primary completion: 2017-09-01
• Completion: 2017-09-01
• First posted: 2017-06-08
• Last updated: 2017-06-08

Locations

1 site across 1 country: Brazil